On the public citation graph

Association between Biologic Therapy and Fracture Incidence in Patients with Selected Rheumatic and Autoimmune Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

https://doi.org/10.2139/ssrn.4058421
0 signed · 30 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/acr.21937openalex-extracted
Initiation of Tumor Necrosis Factor α Antagonists and Risk of Fractures in Patients With Selected Rheumatic and Autoimmune Diseases
inferredcites →https://doi.org/10.1002/acr.22519openalex-extracted
Meta‐Analysis of Tumor Necrosis Factor Inhibitors and Glucocorticoids on Bone Density in Rheumatoid Arthritis and Ankylosing Spondylitis Trials
inferredcites →https://doi.org/10.1002/art.25053openalex-extracted
Rapid and sustained improvement in bone and cartilage turnover markers with the anti–interleukin‐6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double‐blind,…
inferredcites →https://doi.org/10.1002/jbmr.1489openalex-extracted
Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: A population-based cohort study
inferredcites →https://doi.org/10.1007/s00198-012-2113-8openalex-extracted
Osteoporosis drug therapy strategies in the setting of disease-modifying agents for autoimmune disease
inferredcites →https://doi.org/10.1007/s00198-013-2548-6openalex-extracted
IL-17A-mediated sRANK ligand elevation involved in postmenopausal osteoporosis
inferredcites →https://doi.org/10.1007/s00198-016-3769-2openalex-extracted
Biologic therapies and bone loss in rheumatoid arthritis
inferredcites →https://doi.org/10.1007/s00198-018-4491-zopenalex-extracted
Risk of fragility fracture among patients with late-onset psoriasis: a UK population-based study
inferredcites →https://doi.org/10.1007/s00296-008-0576-xopenalex-extracted
Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis
inferredcites →https://doi.org/10.1007/s11657-019-0667-1openalex-extracted
A meta-analysis of secondary osteoporosis in systemic lupus erythematosus: prevalence and risk factors
inferredcites →https://doi.org/10.1007/s11926-012-0252-8openalex-extracted
Inflammatory Rheumatic Disorders and Bone
inferredcites →https://doi.org/10.1016/0002-9343(93)90218-eopenalex-extracted
Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis
inferredcites →https://doi.org/10.1016/j.autrev.2013.03.015openalex-extracted
Biologic therapies and systemic bone loss in rheumatoid arthritis
inferredcites →https://doi.org/10.1016/j.bonr.2017.10.003openalex-extracted
Is osteoporosis an autoimmune mediated disorder?
inferredcites →https://doi.org/10.1016/j.devcel.2005.02.017openalex-extracted
Canonical Wnt Signaling in Differentiated Osteoblasts Controls Osteoclast Differentiation
inferredcites →https://doi.org/10.1016/j.maturitas.2013.09.009openalex-extracted
Inflammatory bowel disease and the risk of osteoporosis and fracture
inferredcites →https://doi.org/10.1016/j.semarthrit.2012.01.004openalex-extracted
IL-6 Receptor Inhibition Positively Modulates Bone Balance in Rheumatoid Arthritis Patients with an Inadequate Response to Anti-Tumor Necrosis Factor Therapy: Biochemical Marker Analysis of Bone Metabolism in the Tocilizumab RADIATE Study (NCT00106522)
inferredcites →https://doi.org/10.1016/j.semarthrit.2014.05.008openalex-extracted
Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: A systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/j.semarthrit.2016.05.005openalex-extracted
Prevalence and risk factors of low bone mineral density in psoriatic arthritis: A systematic review
inferredcites →https://doi.org/10.1074/jbc.271.9.4605openalex-extracted
Interleukin-1α Activates an NF-κB-like Factor in Osteoclast-like Cells
inferredcites →https://doi.org/10.1093/rheumatology/kez655openalex-extracted
The impact of long-term biologics/target therapy on bone mineral density in rheumatoid arthritis: a propensity score-matched analysis
inferredcites →https://doi.org/10.1097/meg.0000000000000719openalex-extracted
A 1-year prospective study of the effect of infliximab on bone metabolism in inflammatory bowel disease patients
inferredcites →https://doi.org/10.1097/rhu.0b013e3181a5679dopenalex-extracted
Factors Influencing Fracture Risk, T Score, and Management of Osteoporosis in Patients With Rheumatoid Arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) Registry
inferredcites →https://doi.org/10.1111/j.1365-2036.2004.02097.xopenalex-extracted
Effect of antitumour necrosis factor‐α therapy on bone turnover in patients with active Crohn's disease: a prospective study
inferredcites →https://doi.org/10.1136/annrheumdis-2016-210441openalex-extracted
The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study
inferredcites →https://doi.org/10.1136/annrheumdis-2019-215328openalex-extracted
Medications associated with fracture risk in patients with rheumatoid arthritis
inferredcites →https://doi.org/10.1136/bmj.d5928openalex-extracted
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
inferredcites →https://doi.org/10.1155/2013/945945openalex-extracted
Bone Effects of Biologic Drugs in Rheumatoid Arthritis
inferredcites →https://doi.org/10.1186/s13075-019-1938-3openalex-extracted
Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients
inferredcites →https://doi.org/10.1186/s42358-021-00179-3openalex-extracted
Osteoporotic fractures in rheumatoid arthritis patients in Argentina: a matched retrospective cohort study
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.